DVSA Diversa (MM)

SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Diversa Corporation (NASDAQ:DVSA), a leader in the development of high-performance specialty enzymes, announced today that its Form 10-K filed with the Securities and Exchange Commission on March 16, 2007 included an audit opinion that contained a going concern qualification. This announcement is being made in order to comply with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires any Nasdaq listed issuer that receives an audit opinion that contains a going concern qualification to make a public announcement through the news media to that effect. Diversa has recently made other public announcements regarding the actions that Diversa is taking to address the circumstances that gave rise to the going concern qualification and Diversa's ongoing liquidity requirements. About Diversa Since 1994, San Diego-based Diversa Corporation has pioneered the development of high-performance specialty enzymes. Diversa possesses the world's broadest array of enzymes derived from bio-diverse environments as well as patented DirectEvolution(R) technologies. Diversa customizes enzymes for manufacturers within the biofuels, industrial, and health and nutrition markets to enable higher throughput, lower costs, and improved environmental outcomes. On February 12, 2007, Diversa entered into a merger agreement with Celunol Corp. pursuant to which a wholly owned subsidiary of Diversa will merge with and into Celunol, with Celunol as the surviving corporation, becoming a wholly owned subsidiary of Diversa. The proposed merger transaction is subject to customary closing conditions, including receipt of certain regulatory approvals and the approval of the stockholders of Diversa and Celunol. For more information, please visit http://www.diversa.com/. Additional Information about the Merger and Where to Find It On March 19, 2007, Diversa filed a registration statement on Form S-4 with the SEC that includes a proxy statement/prospectus and other relevant documents in connection with the proposed merger between Diversa and Celunol and related transactions. Investors and security holders of Diversa and Celunol are urged to read the proxy statement/prospectus (including any amendments or supplements to the proxy statement/prospectus) and other relevant materials, because they contain important information about Diversa, Celunol, and the proposed merger and related transactions. Investors may obtain a free copy of these materials and other documents filed with the SEC at the SEC's website at http://www.sec.gov/. A free copy of the proxy statement/prospectus may also be obtained from Diversa by directing a request to: Diversa Corporation, 4955 Directors Place, San Diego, CA 92121, Attn: Investor Relations. In addition, investors may access copies of the documents filed with the SEC by Diversa on Diversa's website at http://www.diversa.com/. Participants in the Solicitation Diversa and its executive officers and directors and Celunol and its executive officers and directors may be deemed to be participants in the solicitation of proxies from the stockholders of Diversa in connection with the proposed merger between Diversa and Celunol and related transactions. Information regarding the special interests of these executive officers and directors in the proposed merger and related transactions as well as additional information regarding these individuals is included in the proxy statement/prospectus referred to above. This document is available free of charge at the SEC's website at http://www.sec.gov/ and from Investor Relations at Diversa at the address described above. Forward-Looking Statements Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include statements related to the proposed merger with Celunol Corp. Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to differences include, but are not limited to, risks involved with Diversa's ability to close its merger with Celunol Corp., including the risk that the merger may not close for one of a number of reasons. Certain of these factors and others are more fully described in Diversa's filings with the Securities and Exchange Commission, including, but not limited to, Diversa's Annual Report on Form 10-K for the year ended December 31, 2006 and the proxy statement/prospectus referred to above. These forward-looking statements speak only as of the date hereof. Diversa expressly disclaims any intent or obligation to update these forward-looking statements. Contact: Wendy Kelley Investor Relations (858) 526-5437 DATASOURCE: Diversa Corporation CONTACT: Wendy Kelley, Investor Relations of Diversa Corporation, +1-858-526-5437 Web site: http://www.diversa.com/

Copyright